|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
4959737 |
| 003 |
ICU |
| 005 |
20040709113300.0 |
| 008 |
030206s2003 gw a b 101 0 eng |
| 010 |
|
|
|a 2003042705
|
| 020 |
|
|
|a 3540004130 (alk. paper)
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RB155.8
|b .H863 2003
|
| 060 |
1 |
0 |
|a W1
|b ER72 v.43 2003
|
| 060 |
1 |
0 |
|a QZ 50
|b H91632 2003
|
| 082 |
0 |
0 |
|a 616/.042
|2 21
|
| 245 |
0 |
0 |
|a Human gene therapy :
|b current opportunities and future trends /
|c G.M. Rubanyi, S. Ylä-Herttuala, editors.
|
| 260 |
|
|
|a Berlin ;
|a New York :
|b Springer,
|c c2003.
|
| 300 |
|
|
|a xv, 252 p. :
|b ill. ;
|c 21 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Ernst Schering Research Foundation workshop,
|x 0947-6075 ;
|v 43
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t The Future of Gene Therapy /
|r G. J. Nabel --
|g 2.
|t Angiogenesis Clinical Trials /
|r S. Yla-Herttuala --
|g 3.
|t AAV Vectors, the Future Workhorse of Human Gene Therapy /
|r R. J. Samulski --
|g 4.
|t Nonviral Vectors for Cardiovascular Gene Delivery /
|r J. A. Wolff and H. Herweijer --
|g 5.
|t Gene Therapy for Coronary Artery Disease: Preclinical and Initial Clinical Results with Intracoronary Administration of Ad5FGF-4 /
|r M. W. Watkins and G. M. Rubanyi --
|g 6.
|t Cancer Gene Therapy: Present Status and Future Directions /
|r G. J. Nabel --
|g 7.
|t Oncolytic Virotherapy as a Novel Treatment Platform for Cancer /
|r D. Kirn --
|g 8.
|t Adenovirus Retargeting and Systemic Delivery /
|r L. W. Seymour, K. D. Fisher, N. K. Green, S. J. Hale, M. Lyons, V. Mautner, S. Nicum, D. Onion, D. Oupicky, M. Stevenson and K. Ulbrich --
|g 9.
|t CNS Diseases Amenable to Gene Therapy /
|r H. Federoff --
|g 10.
|t Molecular Therapies for the Nervous System and Skeletal Muscle /
|r G. Karpati --
|g 11.
|t Lentivirus: A Vector for Nervous System Applications /
|r S. Kingsman --
|g 12.
|t Endothelial Progenitor Cells for Neovascularization /
|r T. Asahara --
|g 13.
|t Therapeutic Aptamers and Antidotes: A Novel Approach to Safer Drug Design /
|r B. Sullenger, R. R. White and C. P. Rusconi --
|g 14.
|t Plasmid-Based Gene Transfer and Antiprogestin-Controllable Transgene Expression /
|r J. L. Nordstrom.
|
| 650 |
|
0 |
|a Gene therapy
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2009125717
|
| 650 |
1 |
2 |
|a Gene Therapy
|x trends
|v Congresses.
|
| 650 |
|
7 |
|a Gene therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00939638
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Rubanyi, Gabor M.,
|d 1947-
|0 http://id.loc.gov/authorities/names/n88095954
|1 http://viaf.org/viaf/264545373
|
| 700 |
1 |
|
|a Ylä-Herttuala, S.
|q (Seppo),
|d 1957-
|0 http://id.loc.gov/authorities/names/n2003127518
|1 http://viaf.org/viaf/68313567
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)51648243
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 64b96f5b-66fa-5bef-b2d8-705fa927ae84
|s 07efd55d-cd89-5058-8164-c4f0a2e4449f
|
| 928 |
|
|
|t Library of Congress classification
|a RB155.8 .H863 2003
|l ASR
|c ASR-SciASR
|i 6462422
|
| 927 |
|
|
|t Library of Congress classification
|a RB155.8 .H863 2003
|l ASR
|c ASR-SciASR
|e VISI
|e CRERAR
|b 64264511
|i 7524033
|
